Loading…
Clinical management of spasticity
A further problem-particularly in children with spasticity, which is often secondary to cerebral palsy-is the failure of normal muscle growth, resulting in torsion of long bones and consequent joint instability and degeneration. 16 Early identification and intervention to treat spasticity and associ...
Saved in:
Published in: | Journal of neurology, neurosurgery and psychiatry neurosurgery and psychiatry, 2005-04, Vol.76 (4), p.459-463 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-b496t-d2f8832c5fe2d088d7700c75fa365f0c9bc7e8244bc0ac6864fed90d7d2fe2833 |
---|---|
cites | |
container_end_page | 463 |
container_issue | 4 |
container_start_page | 459 |
container_title | Journal of neurology, neurosurgery and psychiatry |
container_volume | 76 |
creator | Thompson, A J Jarrett, L Lockley, L Marsden, J Stevenson, V L |
description | A further problem-particularly in children with spasticity, which is often secondary to cerebral palsy-is the failure of normal muscle growth, resulting in torsion of long bones and consequent joint instability and degeneration. 16 Early identification and intervention to treat spasticity and associated symptoms such as spasms can minimise the development of these long term secondary complications.\n The effect of a single injection often lasts many months and can be repeated if necessary. 25 MONITORING SPASTICITY It is clearly helpful to adopt a management approach that is linked to the severity of the spasticity. Other clinical scales have been used, including clinician visual analogue scales or self report scales for spasm severity and frequency, though none has been shown to be reliable. 28, 29 There is thus still a need for development of a valid, responsive, and reliable scale to assess both the severity and the functional impact of spasticity and its associated features. 30 In addition to clinical scales, more complex techniques including pendulum tests or gait analysis can be employed, as well as simple goniometers allowing ranges of movement in relevant joints to be recorded and monitored. 31 In our experience several measures are necessary to complete a thorough evaluation of the severity and impact of an individual's spasticity. |
doi_str_mv | 10.1136/jnnp.2004.035972 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1739594</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4023804231</sourcerecordid><originalsourceid>FETCH-LOGICAL-b496t-d2f8832c5fe2d088d7700c75fa365f0c9bc7e8244bc0ac6864fed90d7d2fe2833</originalsourceid><addsrcrecordid>eNqFkM1Lw0AQxRdRbK3ePUnFo6RO9jsXQYpWoSpaleJl2Ww2NbVJajYV-9-7JaXqybnMYX7vzeMhdBhCLwwJP5sWxbyHAWgPCIsE3kLtkHIZEALjbdQGwDggwKCF9pybwmpktItaIROCUsza6Lg_y4rM6Fk314We2NwWdbdMu26uXZ2ZrF7uo51Uz5w9WO8Oer66fOpfB8P7wU3_YhjENOJ1kOBUSoINSy1OQMpECAAjWKoJZymYKDbCSkxpbEAbLjlNbRJBIrzQYklIB503vvNFnNvE-CCVnql5leW6WqpSZ-rvpcje1KT8VKEgEYuoNzhZG1Tlx8K6Wk3LRVX4zB6RISYSR9xT0FCmKp2rbLr5EIJalapWpapVqaop1UuOfif7Eaxb9EDQAJmr7dfmrqt3xQURTN299NVoNOC3D4-vauz504aP8-n_778BkFSQIg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1781238296</pqid></control><display><type>article</type><title>Clinical management of spasticity</title><source>PubMed Central(OpenAccess)</source><creator>Thompson, A J ; Jarrett, L ; Lockley, L ; Marsden, J ; Stevenson, V L</creator><creatorcontrib>Thompson, A J ; Jarrett, L ; Lockley, L ; Marsden, J ; Stevenson, V L</creatorcontrib><description>A further problem-particularly in children with spasticity, which is often secondary to cerebral palsy-is the failure of normal muscle growth, resulting in torsion of long bones and consequent joint instability and degeneration. 16 Early identification and intervention to treat spasticity and associated symptoms such as spasms can minimise the development of these long term secondary complications.\n The effect of a single injection often lasts many months and can be repeated if necessary. 25 MONITORING SPASTICITY It is clearly helpful to adopt a management approach that is linked to the severity of the spasticity. Other clinical scales have been used, including clinician visual analogue scales or self report scales for spasm severity and frequency, though none has been shown to be reliable. 28, 29 There is thus still a need for development of a valid, responsive, and reliable scale to assess both the severity and the functional impact of spasticity and its associated features. 30 In addition to clinical scales, more complex techniques including pendulum tests or gait analysis can be employed, as well as simple goniometers allowing ranges of movement in relevant joints to be recorded and monitored. 31 In our experience several measures are necessary to complete a thorough evaluation of the severity and impact of an individual's spasticity.</description><identifier>ISSN: 0022-3050</identifier><identifier>EISSN: 1468-330X</identifier><identifier>DOI: 10.1136/jnnp.2004.035972</identifier><identifier>PMID: 15774425</identifier><identifier>CODEN: JNNPAU</identifier><language>eng</language><publisher>England: BMJ Publishing Group Ltd</publisher><subject>Algorithms ; Botulinum Toxins, Type A - therapeutic use ; Cerebral palsy ; Cerebral Palsy - complications ; Cerebral Palsy - pathology ; Cerebral Palsy - therapy ; Electric Stimulation Therapy - methods ; Fecal Incontinence - etiology ; Fecal Incontinence - physiopathology ; FES ; functional electrical stimulation ; Humans ; management ; Motor Neurons - pathology ; Movement Disorders - diagnosis ; Movement Disorders - etiology ; Movement Disorders - therapy ; Multiple sclerosis ; Neural Inhibition - physiology ; Neuromuscular Agents - therapeutic use ; Pain ; Patient Care Team ; Physical Therapy Modalities ; Severity of Illness Index ; spasticity ; Spinal cord ; treatment ; UMN ; upper motor neurone ; Urinary Bladder Diseases - etiology ; Urinary Bladder Diseases - physiopathology</subject><ispartof>Journal of neurology, neurosurgery and psychiatry, 2005-04, Vol.76 (4), p.459-463</ispartof><rights>Copyright 2005 Journal of Neurology Neurosurgery and Psychiatry</rights><rights>Copyright: 2005 Copyright 2005 Journal of Neurology Neurosurgery and Psychiatry</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b496t-d2f8832c5fe2d088d7700c75fa365f0c9bc7e8244bc0ac6864fed90d7d2fe2833</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1739594/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1739594/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15774425$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thompson, A J</creatorcontrib><creatorcontrib>Jarrett, L</creatorcontrib><creatorcontrib>Lockley, L</creatorcontrib><creatorcontrib>Marsden, J</creatorcontrib><creatorcontrib>Stevenson, V L</creatorcontrib><title>Clinical management of spasticity</title><title>Journal of neurology, neurosurgery and psychiatry</title><addtitle>J Neurol Neurosurg Psychiatry</addtitle><description>A further problem-particularly in children with spasticity, which is often secondary to cerebral palsy-is the failure of normal muscle growth, resulting in torsion of long bones and consequent joint instability and degeneration. 16 Early identification and intervention to treat spasticity and associated symptoms such as spasms can minimise the development of these long term secondary complications.\n The effect of a single injection often lasts many months and can be repeated if necessary. 25 MONITORING SPASTICITY It is clearly helpful to adopt a management approach that is linked to the severity of the spasticity. Other clinical scales have been used, including clinician visual analogue scales or self report scales for spasm severity and frequency, though none has been shown to be reliable. 28, 29 There is thus still a need for development of a valid, responsive, and reliable scale to assess both the severity and the functional impact of spasticity and its associated features. 30 In addition to clinical scales, more complex techniques including pendulum tests or gait analysis can be employed, as well as simple goniometers allowing ranges of movement in relevant joints to be recorded and monitored. 31 In our experience several measures are necessary to complete a thorough evaluation of the severity and impact of an individual's spasticity.</description><subject>Algorithms</subject><subject>Botulinum Toxins, Type A - therapeutic use</subject><subject>Cerebral palsy</subject><subject>Cerebral Palsy - complications</subject><subject>Cerebral Palsy - pathology</subject><subject>Cerebral Palsy - therapy</subject><subject>Electric Stimulation Therapy - methods</subject><subject>Fecal Incontinence - etiology</subject><subject>Fecal Incontinence - physiopathology</subject><subject>FES</subject><subject>functional electrical stimulation</subject><subject>Humans</subject><subject>management</subject><subject>Motor Neurons - pathology</subject><subject>Movement Disorders - diagnosis</subject><subject>Movement Disorders - etiology</subject><subject>Movement Disorders - therapy</subject><subject>Multiple sclerosis</subject><subject>Neural Inhibition - physiology</subject><subject>Neuromuscular Agents - therapeutic use</subject><subject>Pain</subject><subject>Patient Care Team</subject><subject>Physical Therapy Modalities</subject><subject>Severity of Illness Index</subject><subject>spasticity</subject><subject>Spinal cord</subject><subject>treatment</subject><subject>UMN</subject><subject>upper motor neurone</subject><subject>Urinary Bladder Diseases - etiology</subject><subject>Urinary Bladder Diseases - physiopathology</subject><issn>0022-3050</issn><issn>1468-330X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNqFkM1Lw0AQxRdRbK3ePUnFo6RO9jsXQYpWoSpaleJl2Ww2NbVJajYV-9-7JaXqybnMYX7vzeMhdBhCLwwJP5sWxbyHAWgPCIsE3kLtkHIZEALjbdQGwDggwKCF9pybwmpktItaIROCUsza6Lg_y4rM6Fk314We2NwWdbdMu26uXZ2ZrF7uo51Uz5w9WO8Oer66fOpfB8P7wU3_YhjENOJ1kOBUSoINSy1OQMpECAAjWKoJZymYKDbCSkxpbEAbLjlNbRJBIrzQYklIB503vvNFnNvE-CCVnql5leW6WqpSZ-rvpcje1KT8VKEgEYuoNzhZG1Tlx8K6Wk3LRVX4zB6RISYSR9xT0FCmKp2rbLr5EIJalapWpapVqaop1UuOfif7Eaxb9EDQAJmr7dfmrqt3xQURTN299NVoNOC3D4-vauz504aP8-n_778BkFSQIg</recordid><startdate>200504</startdate><enddate>200504</enddate><creator>Thompson, A J</creator><creator>Jarrett, L</creator><creator>Lockley, L</creator><creator>Marsden, J</creator><creator>Stevenson, V L</creator><general>BMJ Publishing Group Ltd</general><general>BMJ Publishing Group LTD</general><general>BMJ Group</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M2P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>5PM</scope></search><sort><creationdate>200504</creationdate><title>Clinical management of spasticity</title><author>Thompson, A J ; Jarrett, L ; Lockley, L ; Marsden, J ; Stevenson, V L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b496t-d2f8832c5fe2d088d7700c75fa365f0c9bc7e8244bc0ac6864fed90d7d2fe2833</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Algorithms</topic><topic>Botulinum Toxins, Type A - therapeutic use</topic><topic>Cerebral palsy</topic><topic>Cerebral Palsy - complications</topic><topic>Cerebral Palsy - pathology</topic><topic>Cerebral Palsy - therapy</topic><topic>Electric Stimulation Therapy - methods</topic><topic>Fecal Incontinence - etiology</topic><topic>Fecal Incontinence - physiopathology</topic><topic>FES</topic><topic>functional electrical stimulation</topic><topic>Humans</topic><topic>management</topic><topic>Motor Neurons - pathology</topic><topic>Movement Disorders - diagnosis</topic><topic>Movement Disorders - etiology</topic><topic>Movement Disorders - therapy</topic><topic>Multiple sclerosis</topic><topic>Neural Inhibition - physiology</topic><topic>Neuromuscular Agents - therapeutic use</topic><topic>Pain</topic><topic>Patient Care Team</topic><topic>Physical Therapy Modalities</topic><topic>Severity of Illness Index</topic><topic>spasticity</topic><topic>Spinal cord</topic><topic>treatment</topic><topic>UMN</topic><topic>upper motor neurone</topic><topic>Urinary Bladder Diseases - etiology</topic><topic>Urinary Bladder Diseases - physiopathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thompson, A J</creatorcontrib><creatorcontrib>Jarrett, L</creatorcontrib><creatorcontrib>Lockley, L</creatorcontrib><creatorcontrib>Marsden, J</creatorcontrib><creatorcontrib>Stevenson, V L</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>ProQuest Science Journals</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of neurology, neurosurgery and psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thompson, A J</au><au>Jarrett, L</au><au>Lockley, L</au><au>Marsden, J</au><au>Stevenson, V L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical management of spasticity</atitle><jtitle>Journal of neurology, neurosurgery and psychiatry</jtitle><addtitle>J Neurol Neurosurg Psychiatry</addtitle><date>2005-04</date><risdate>2005</risdate><volume>76</volume><issue>4</issue><spage>459</spage><epage>463</epage><pages>459-463</pages><issn>0022-3050</issn><eissn>1468-330X</eissn><coden>JNNPAU</coden><abstract>A further problem-particularly in children with spasticity, which is often secondary to cerebral palsy-is the failure of normal muscle growth, resulting in torsion of long bones and consequent joint instability and degeneration. 16 Early identification and intervention to treat spasticity and associated symptoms such as spasms can minimise the development of these long term secondary complications.\n The effect of a single injection often lasts many months and can be repeated if necessary. 25 MONITORING SPASTICITY It is clearly helpful to adopt a management approach that is linked to the severity of the spasticity. Other clinical scales have been used, including clinician visual analogue scales or self report scales for spasm severity and frequency, though none has been shown to be reliable. 28, 29 There is thus still a need for development of a valid, responsive, and reliable scale to assess both the severity and the functional impact of spasticity and its associated features. 30 In addition to clinical scales, more complex techniques including pendulum tests or gait analysis can be employed, as well as simple goniometers allowing ranges of movement in relevant joints to be recorded and monitored. 31 In our experience several measures are necessary to complete a thorough evaluation of the severity and impact of an individual's spasticity.</abstract><cop>England</cop><pub>BMJ Publishing Group Ltd</pub><pmid>15774425</pmid><doi>10.1136/jnnp.2004.035972</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-3050 |
ispartof | Journal of neurology, neurosurgery and psychiatry, 2005-04, Vol.76 (4), p.459-463 |
issn | 0022-3050 1468-330X |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1739594 |
source | PubMed Central(OpenAccess) |
subjects | Algorithms Botulinum Toxins, Type A - therapeutic use Cerebral palsy Cerebral Palsy - complications Cerebral Palsy - pathology Cerebral Palsy - therapy Electric Stimulation Therapy - methods Fecal Incontinence - etiology Fecal Incontinence - physiopathology FES functional electrical stimulation Humans management Motor Neurons - pathology Movement Disorders - diagnosis Movement Disorders - etiology Movement Disorders - therapy Multiple sclerosis Neural Inhibition - physiology Neuromuscular Agents - therapeutic use Pain Patient Care Team Physical Therapy Modalities Severity of Illness Index spasticity Spinal cord treatment UMN upper motor neurone Urinary Bladder Diseases - etiology Urinary Bladder Diseases - physiopathology |
title | Clinical management of spasticity |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T13%3A51%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20management%20of%20spasticity&rft.jtitle=Journal%20of%20neurology,%20neurosurgery%20and%20psychiatry&rft.au=Thompson,%20A%20J&rft.date=2005-04&rft.volume=76&rft.issue=4&rft.spage=459&rft.epage=463&rft.pages=459-463&rft.issn=0022-3050&rft.eissn=1468-330X&rft.coden=JNNPAU&rft_id=info:doi/10.1136/jnnp.2004.035972&rft_dat=%3Cproquest_pubme%3E4023804231%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b496t-d2f8832c5fe2d088d7700c75fa365f0c9bc7e8244bc0ac6864fed90d7d2fe2833%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1781238296&rft_id=info:pmid/15774425&rfr_iscdi=true |